Health Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19 January 20, 2021
Health Evoke Pharma Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares January 20, 2021
Health EDAP Announces Record Preliminary Unaudited Fourth Quarter 2020 Revenue of EUR 15.3 Million [$18.3 million], an Increase of 28% Year-Over-Year January 20, 2021
Health Bionano Genomics Announces Pricing of $200 Million Underwritten Public Offering of Common Stock January 20, 2021
Health Viveve Announces Closing of an Upsized $27.6 Million Underwritten Public Offering and Exercise of Over-Allotment Option January 19, 2021
Health Neovasc Reducer Featured in Three Peer Reviewed Publications Supporting Reducer Therapy January 19, 2021